CA3242778A1 - A coagulation mold, a kit and a method for preparing a coagulated blood mass - Google Patents

A coagulation mold, a kit and a method for preparing a coagulated blood mass

Info

Publication number
CA3242778A1
CA3242778A1 CA3242778A CA3242778A CA3242778A1 CA 3242778 A1 CA3242778 A1 CA 3242778A1 CA 3242778 A CA3242778 A CA 3242778A CA 3242778 A CA3242778 A CA 3242778A CA 3242778 A1 CA3242778 A1 CA 3242778A1
Authority
CA
Canada
Prior art keywords
coagulation
blood
coagulated blood
mass
blood mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3242778A
Other languages
English (en)
French (fr)
Inventor
Alon Kushnir
Original Assignee
Reddress Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddress Medical Ltd filed Critical Reddress Medical Ltd
Publication of CA3242778A1 publication Critical patent/CA3242778A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Manufacturing & Machinery (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA3242778A 2022-01-25 2023-01-25 A coagulation mold, a kit and a method for preparing a coagulated blood mass Pending CA3242778A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL290122 2022-01-25
IL290122A IL290122B2 (en) 2022-01-25 2022-01-25 Clotting template, kit and method for making a blood clot
PCT/IL2023/050083 WO2023144818A1 (en) 2022-01-25 2023-01-25 A coagulation mold, a kit and a method for preparing a coagulated blood mass

Publications (1)

Publication Number Publication Date
CA3242778A1 true CA3242778A1 (en) 2023-08-03

Family

ID=85238983

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3242778A Pending CA3242778A1 (en) 2022-01-25 2023-01-25 A coagulation mold, a kit and a method for preparing a coagulated blood mass

Country Status (11)

Country Link
US (4) US12397018B2 (https=)
EP (1) EP4447889A1 (https=)
JP (1) JP2025504710A (https=)
KR (1) KR20240144143A (https=)
CN (1) CN118613239A (https=)
AU (1) AU2023214201A1 (https=)
CA (1) CA3242778A1 (https=)
IL (1) IL290122B2 (https=)
MX (1) MX2024009036A (https=)
WO (1) WO2023144818A1 (https=)
ZA (1) ZA202406452B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025243305A1 (en) 2024-05-23 2025-11-27 Reddress Ltd. Controlled drug delivery
EP4686486A1 (en) * 2024-07-30 2026-02-04 Paul Hartmann AG Gel composition comprising whole blood

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2381969T3 (en) * 2009-01-27 2016-09-05 Reddress Ltd METHODS OF MAKING wound dressings AND A BANK wound dressings
IL254636A0 (en) 2017-09-24 2017-11-30 Reddress Ltd System and method for preparing a wound dressing
IL257229B (en) 2018-01-30 2022-07-01 Reddress Ltd Blood applicator for tissue treatment

Also Published As

Publication number Publication date
CN118613239A (zh) 2024-09-06
EP4447889A1 (en) 2024-10-23
US12397018B2 (en) 2025-08-26
IL290122B2 (en) 2023-08-01
WO2023144818A1 (en) 2023-08-03
US20250161353A1 (en) 2025-05-22
AU2023214201A2 (en) 2024-08-15
MX2024009036A (es) 2024-08-06
US20250114399A1 (en) 2025-04-10
KR20240144143A (ko) 2024-10-02
IL290122B1 (en) 2023-04-01
US20240374636A1 (en) 2024-11-14
US20250186488A1 (en) 2025-06-12
IL290122A (https=) 2022-03-01
AU2023214201A1 (en) 2024-08-08
ZA202406452B (en) 2025-04-30
JP2025504710A (ja) 2025-02-17
US12364713B2 (en) 2025-07-22
US12599629B2 (en) 2026-04-14

Similar Documents

Publication Publication Date Title
ZA202406452B (en) A coagulation mold, a kit and a method for preparing a coagulated blood mass
Wang et al. Synthesis and characterization of an injectable ε-polylysine/carboxymethyl chitosan hydrogel used in medical application
JP6076947B2 (ja) 硬化性二部型アクリル系組成物及びその生成方法
CN105705171B (zh) 通过胶原蛋白和玻尿酸的天然交联强化其橡胶性质物性的生体材料物质及其制造方法和使用方法
JP2020501702A (ja) 生分解性高分子の多孔性微粒子、及びそれを含む高分子フィラー
JP5847097B2 (ja) 骨造成のための骨セメント系
GB2377642A (en) Prosthetic filler for a living body and method of manufacturing the prosthetic filler
Combs et al. The effects of barium sulfate on the polymerization temperature and shear strength of surgical simplex P
JP2002331026A (ja) 整形外科用充填材料およびその使用法
CN105251061B (zh) 一种可生物降解的术后防粘连复合膜及其制备方法
US20240290224A1 (en) Synthetic thrombus model for learning the surgical removal of a blood clot in the context of a treatment readjustment
CN113368214A (zh) 多肽在制备创伤治疗药物中的用途
JP7805600B2 (ja) 架橋されたハイドロゲルを利用した体内注入型ハイドロゲルロッド、その製造方法及びその生医学的用途
US20160114079A1 (en) Composite Grafts, Systems, and Methods
JPH0965848A (ja) 油揚類の製造方法
Khanekar et al. Application of 25 factorial design in optimization of superporous hydrogel synthesis containing natural mucilage
CN102049063A (zh) 一种用于制备可膨胀义眼台的材料及其应用
RU2350303C1 (ru) Способ микроинъекционной трансплантации по в.а. черешневу
CN108310008A (zh) 胶体金在制备人工脑脊液试剂中的应用
Normahira et al. Biomimetic porosity of gelatin-hydroxyapatite scaffold for bone tissue
JP3101999B2 (ja) 人工骨及び人工歯とその製造法
Arun¹ et al. Factors Affecting In-Situ Properties
CN104177746A (zh) 用于热损伤治疗弹性监控研究的透明体模制作方法
BR102018069228A2 (pt) Implante intraocular de pmma com liberação de substância hipotensora por edição genética
CN107998457A (zh) 一种医用植入多孔材料

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20240703

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20240703

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W00-W00-W128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INACTIVE: IPC ASSIGNED

Effective date: 20240704

Free format text: ST27 STATUS EVENT CODE: A-1-1-W00-W00-W005 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: INACTIVE: FIRST IPC ASSIGNED

Effective date: 20240704

P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20250429

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260106

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260106